miRagen Therapeutics

miRagen Therapeutics

miRagen Therapeutics

miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.
Founded
2007
Raised
$60.5M
Follow us
Alexa global traffic share
Twitter followers
Team Size
10+
Employees
$40,000,000 Venture capital (Series D)
PE Hub

Miragen racks up $40 mln, will merge with Signal Genetics